(19) |
 |
|
(11) |
EP 2 014 772 A8 |
(12) |
CORRECTED EUROPEAN PATENT APPLICATION |
|
Note: Bibliography reflects the latest situation |
(15) |
Correction information: |
|
Corrected version no 1 (W1 A2) |
(48) |
Corrigendum issued on: |
|
29.04.2009 Bulletin 2009/18 |
(43) |
Date of publication: |
|
14.01.2009 Bulletin 2009/03 |
(22) |
Date of filing: 03.04.1997 |
|
(51) |
International Patent Classification (IPC):
|
|
(84) |
Designated Contracting States: |
|
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
(30) |
Priority: |
03.03.1997 US 39532 P 21.06.1996 US 20196 P 05.06.1996 US 19372 P 05.04.1996 US 14943 P
|
(62) |
Application number of the earlier application in accordance with Art. 76 EPC: |
|
97920115.9 / 0906448 |
(71) |
Applicant: Giordano, Antonio |
|
Philadelphia,
Pennsylvania 19128 (US) |
|
(72) |
Inventors: |
|
- Giordano, Antonio
Philadelphia, Pennsylvania 19128 (US)
- Baldi, Alfonso
80128 Naples (IT)
|
(74) |
Representative: Thomas, Dean et al |
|
Cabinet Ores
36 Rue de St Pétersbourg 75008 Paris 75008 Paris (FR) |
|
|
|
|
|
Remarks: |
|
This application was filed on 27-05-2008 as a divisional application to the application
mentioned under INID code 62. |
|
(54) |
Method for the diagnosis and prognosis of cancer |
(57) The invention provides diagnostic and prognostic methods which comprise determining
the level of expression of the tumor suppressor gene pRb2/p130, because the relative
level of pRb2/p130 expression correlates with the presence of cancer, tumor grade
and patient prognosis. These methods may be used to detect cancer, to make treatment
decisions, to predict patient outcome, and to predict the risk of cancer in disease-free
individuals. The invention further provides methods for the detection of mutations
and polymorphisms in the pRb2/p130 gene, which may be used to characterize genetic
events associated with tumor formation, to trace the parental origin of mutations,
to identify carriers of germline mutations and to identify individuals with a predisposition
to cancer.